JOHN DAVID HANSEN Insider Trading $AVNR AVANIR PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN DAVID HANSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN DAVID HANSEN. JOHN DAVID HANSEN is V.P. of Corporate Development in AVANIR PHARMACEUTICALS, INC. ($AVNR) and President and CEO in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
JOHN DAVID HANSEN in AVANIR PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN DAVID HANSEN: V.P. of Corporate Development
Holdings: 15,000 shares
Latest Transaction: Jan 03 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN DAVID HANSEN in AVANIR PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.40 | 10,200 | 34,680 | 15,000 | 25.2 K to 15 K (-40.48 %) |
| Jan 03 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.39 | 4,800 | 16,254 | 25,200 | 30 K to 25.2 K (-16.00 %) |
| Jan 03 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.42 | 600 | 2,052 | 15,000 | 15.6 K to 15 K (-3.85 %) |
| Jan 03 2005 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.41 | 14,400 | 49,044 | 15,600 | 30 K to 15.6 K (-48.00 %) |
| Nov 12 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Option Exercise | A | 3.46 | 50,000 | 173,000 | 50,000 | |
| Sep 14 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.15 | 15,000 | 47,259 | 30,000 | 45 K to 30 K (-33.33 %) |
| Sep 14 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Sell | S | 3.15 | 15,000 | 47,259 | 30,000 | 45 K to 30 K (-33.33 %) |
| Apr 08 2004 | AVNR | AVANIR PHARMACEUTI ... | HANSEN JOHN DAVID | V.P. of Corporate D ... | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 |
Page: 1